机构:[1]Department of Neurology, Xuan Wu Hospital of the Capital Medical University, and Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing, China神经内科首都医科大学宣武医院[2]Department of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA
We previously described an association between Alzheimer's disease (AD) and a single-nucleotide polymorphism -980C/G (rs3754048) in the promoter of the anterior pharynx-defective-1a (APH-1A) gene. Here, we examine the potential of this -980C/G polymorphism to affect APH-1A transcription and confer a risk of AD. We validated the presence of APH-1A promoter polymorphism -980C/G in other two Chinese cohort sets (450 AD and 450 controls). Subsequently, we measured APH-1A mRNA and protein levels and gamma-secretase activity in C or G allele carriers. Finally, we examined the polymorphism's transcriptional function using a dual-luciferase reporter assay and also tracked transcription factor binding to the variant promoter sequence with electrophoretic mobility shift assays (EMSAs). We found that the APH-1A levels and gamma-secretase activity were higher in individuals carrying allele G. The G allele increased APH-1A transcriptional activity significantly in both N2A cells and HEK293 cells. The EMSA revealed an increased binding of the transcription factor Yin Yang 1 (YY1) to allele G. Overexpression of YY1 resulted in an activation of the APH-1A promoter (2.7-fold). Specific YY1 siRNA led to decreases in APH-1A promoter activity and mRNA and protein levels. Our data indicate that the APH-1A promoter polymorphism -980C/G might alter the binding ability of YY1 transcription factor, resulting in an increased level of APH-1A and gamma-secretase activity. These factors further facilitated beta-amyloid (Ab) 42 generation and ultimately modified patients' susceptibility to AD. The involvement of transcription factor YY1 might be a novel mechanism for the development of AD.
基金:
National Natural Science Key Foundation of China (30830045), National Key Technology R&D Program in the Eleventh Five-year Plan Period (2006BAI02B01), China National Nature Science Foundation (81000472),
and Beijing Natural Science Foundation (7102071).
第一作者机构:[1]Department of Neurology, Xuan Wu Hospital of the Capital Medical University, and Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing, China
通讯作者:
通讯机构:[*]Department of Neurology, Xuan Wu Hospital of the Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714):
Wei Qin ,Longfei Jia ,Aihong Zhou,et al.The-980C/G polymorphism in APH-1A promoter confers risk of Alzheimer's disease[J].AGING CELL.2011,10(4):711-719.doi:10.1111/j.1474-9726.2011.00708.x.
APA:
Wei Qin,,Longfei Jia,,Aihong Zhou,Xiumei Zuo,,Zhe Cheng,...&Jianping Jia.(2011).The-980C/G polymorphism in APH-1A promoter confers risk of Alzheimer's disease.AGING CELL,10,(4)
MLA:
Wei Qin,,et al."The-980C/G polymorphism in APH-1A promoter confers risk of Alzheimer's disease".AGING CELL 10..4(2011):711-719